scispace - formally typeset
W

William A. Hanlon

Researcher at Merck & Co.

Publications -  21
Citations -  1557

William A. Hanlon is an academic researcher from Merck & Co.. The author has contributed to research in topics: Laropiprant & Elastase. The author has an hindex of 11, co-authored 21 publications receiving 1494 citations.

Papers
More filters
Journal ArticleDOI

Integrated Genomic and Proteomic Analyses of Gene Expression in Mammalian Cells

TL;DR: Although the overall pattern of protein expression is similar to that of mRNA expression, the incongruent expression between mRNAs and proteins emphasize the importance of posttranscriptional regulatory mechanisms in cellular development or perturbation that can be unveiled only through integrated analyses of both proteins and m RNAs.
Journal ArticleDOI

L-selectin signaling of neutrophil adhesion and degranulation involves p38 mitogen-activated protein kinase.

TL;DR: Data suggest that signal transduction as a result of clustering L-selectin utilizes p38 MAPK to effect neutrophil shape change, integrin activation, and the release of secondary, tertiary, and secretory granules.
Journal Article

Role of stress-activated mitogen-activated protein kinase (p38) in beta 2-integrin-dependent neutrophil adhesion and the adhesion-dependent oxidative burst.

TL;DR: P38 functions in PMN to signal leukocyte integrin-dependent adhesion and the subsequent massive production of reactive oxygen intermediates, suggesting that p38 kinase activity was required throughout the lag but not after the oxidase was assembled.
Journal ArticleDOI

Serum-induced monocyte differentiation and monocyte chemotaxis are regulated by the p38 MAP kinase signal transduction pathway.

TL;DR: The data in this report suggest that the mechanism by which L‐790,070 blocked monocyte differentiation and prevented chemotaxis was by inhibiting p38 MAP kinase activity.